Search results
Novo Nordisk Investing $6 Billion to Increase Access to Ozempic and Wegovy amid Nationwide Shortage
People Magazine· 3 days agoNovo Nordisk is investing $6.5 billion to increase production of Ozempic and Wegovy. The...
Novo Nordisk To Slash Prices On Buzzy Drugs Ozempic and Wegovy
Futurism via Yahoo Finance· 2 days agoNovo Nordisk, the Danish maker of the injectable diabetes drug Ozempic and its sister weight-loss...
Novo Nordisk announces $6B investment in Ozempic, Wegovy amid shortages
Good Morning America via Yahoo News· 2 days agoNovo Nordisk, the maker of popular drugs used for weight loss including Ozempic and Wegovy, says it...
Opinion | Patients Hitting GLP-1 Plateaus? Here's How to Help
MedPage Today· 5 days agoDrugs like semaglutide (Wegovy) and tirzepatide (Zepbound) are changing the game in obesity care. In...
Novo Nordisk announces $6B investment in Ozempic, Wegovy amid shortages
ABC News· 2 days agoAn executive for Novo Nordisk, the maker of popular drugs used for weight loss including Ozempic and...
FTC Challenges 'Bogus' Patents on Ozempic and Other Drugs
MedPage Today· 4 days agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster weight-...
When supplies resume, should governments subsidise drugs like Ozempic for weight loss? We asked 5...
The Conversation· 6 days agoNeither Ozempic nor Wegovy are listed on the PBS to treat obesity. When Wegovy becomes available, users will need to pay the full price. Or should the government subsidise it?
Patients on hunt for diabetes, obesity and weight-loss drugs - Indianapolis Business Journal
Indianapolis Business Journal· 2 days agoThe phone rings steadily at Phillips Drugs in Richmond these days, with callers asking if the...
What is behind the insulin shortage in the US?
Al Jazeera· 3 days agoSkye Murphy, who is 22 years old, has lived with type 1 diabetes since she was 14. In the past month, she learned that there would be a 30-to-60-day...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
NBC Washington· 4 days agoFederal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-...